期刊文献+

铂类药物的不良反应及其防治 被引量:15

Adverse reactions, prevention and treatment of platinum compounds
下载PDF
导出
摘要 铂类药物是目前临床应用最广泛的抗肿瘤药物类别之一,但因存在不同类型和程度的不良反应,故预防和降低不良反应的发生对提高患者的生活质量和减少额外的治疗费用具有重要意义。本文综述铂类药物的各种不良反应的发生机制及其防治方法,以期为使用铂类药物进行个体化治疗提供参考。 Platinum compounds is one of the most widely used anti-tumor drugs for many types of malignant tumors. However, in view of different types and levels of adverse reactions, it is vital to prevent and reduce the occurrence of these adverse reactions so as to improve the quality of life and lower the extra cost of their treatment. The mechanism, prevention and treatment of various platinum-associated adverse reactions are reviewed so that a certain guide can be provided for the individualization of platinum-based therapy.
作者 王理伟 蔡讯
出处 《上海医药》 CAS 2013年第23期6-10,共5页 Shanghai Medical & Pharmaceutical Journal
关键词 铂类药物 不良反应 化疗 预防 platinum compounds adverse reactions chemotherapy prevention
  • 相关文献

参考文献35

  • 1Rosenberg B, van Camp L, Krigas T. Platinum complexes [J]. Nature, 1965, 205(4972): 698-699.
  • 2Rosenberg B, van Camp L, Grimley EB, et al. The inhibition of growth or cell division in Escherichia coli by different ionic species of platinum (IV) complexes [J]. J Biol Chem, 1967, 242(6): 1347-1352.
  • 3Kin YK, Byun HS, Kim YH, et al. Effects of cisplatin on renal function in rabbits: mechanism of reduced glucose reabsorption [J]. Toxicol Appl Pharmacol, 1995, 130(1): 19- 26.
  • 4Rajeswaran A, Trojan A, Burnand B, et al. Efficacy and side effects of cisplatin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: a systematic review of randomized controlled trials [J]. Lung Cancer, 2008, 59(1): 1-11.
  • 5Hecquet B, Meynadier J, Bonneterre J, et al. Time dependency in plasmatic protein binding of cisplatin [J]. Cancer Treat Rep, 1985, 69(1): 79-83.
  • 6Zhang JS, Imai T, Otagiri M. Effect of a cisplatin-chondroitin sulfate A complex in reducing the nephrotoxicity of cisplatin [J]. Arch Toxicol, 2000, 74(6): 300-307.
  • 7Litterst CL. Alteration in the toxicity of cis- dichlorodiamleineplattinum-II and in tissue localization of platinum as a function of NaC1 concentration in the vehicle of administration [J]. Toxicol Appl Pharmacol, 1981, 61(1): 99- 108.
  • 8谭群友,孟德胜,陈亮,吴畏,张景勍,王如文,蒋耀光.国产氨磷汀预防顺铂肾毒性的临床研究[J].中国医院用药评价与分析,2002,2(6):346-347. 被引量:2
  • 9周际昌,周立强.硒预防顺铂肾毒性的临床观察[J].中华医学杂志,1993,73(11):681-681. 被引量:7
  • 10Oriana S, B6hm S, Spatti G, et al. A preliminary clinical experience with reduced glutathione as protector against cisplatin-toxicity [J]. Tumori, 1987, 73(4): 337-340.

二级参考文献9

共引文献14

同被引文献170

引证文献15

二级引证文献113

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部